News

There is still a series of misunderstandings and ignorance regarding Alzheimer’s disease, according to a survey conducted by the Alzheimer’s Association, which showed that 59 percent of the people surveyed wrongly believe that the disease is a normal part of aging, and 40 percent of them don’t think Alzheimer’s is deadly. The survey,…

A new study entitled “Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer’s Disease,” published in the online issue of Neuron, reports the discovery of a key pathway to the progression of Alzheimer’s Disease. Alzheimer’s disease is characterized by synaptic…

The Healthcare Education Services, an entity certified by the Faculty of Pharmaceutical Medicine for Continuing Professional Development, is offering a course on Alzheimer’s designed for professionals who deal with patients suffering from the disease, as well as for researchers. “Alzheimer’s Disease: An Overview” is taking place between October 1…

An independent expert from the United Nations recently alerted the organization’s member states on the need to protect dementia patients, especially older ones, from stigmatization, discrimination, victimization, and neglect, as he spoke to celebrate the World Alzheimer’s Day, which is marked annually on September 21th. The UN believes that concerted actions are needed in…

Findings of a new study from the University of Wisconsin-Madison’s Waisman Center investigating the link between a protein typically associated with Alzheimer’s disease, are revealing more information about the earliest stages of the neurodegenerative disease and that this protein’s impact on memory and cognition may not be as clear…

A research project designed to create a molecular map with thousands of proteins in the brain with Alzheimer’s disease, conducted by Dr. Richard Unwin, from The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust has been granted a £30,000 ($48,600 dollars) award by Alzheimer’s Research UK. The…

A novel, wearable sensor system created for dementia patients helps to keep them safe when they wander out of bed during the night while also providing relief to their families and caregivers. The system, which connects to a smartphone, is not only innovative, but is also…

Experts from around the globe gathered in Toronto last week to discuss new approaches to the challenge increasing rates dementia present at an Organization for Economic Co-operation and Development (OECD) workshop organized in partnership with the Ontario Brain Institute (OBI) and the Institute of Health Policy, Management…

Pennsylvania-based Representative Chaka Fattah — a U.S. Congressman behind the Fattah Neuroscience Initiative, which aims to drive collaborative Federal research on brain cognition, development, disease and injury — recently had a meeting with World Dementia Envoy and head of the World Dementia Council, Dr. Dennis Gillings, to…

AstraZeneca and Eli Lilly and Company have reached an agreement for the development and commercialization of the oral beta secretes cleaving enzyme (BACE) inhibitor, AZD3293, which might become a viable treatment for Alzheimer’s disease. The oral therapy is expected to prevent the formation of…